Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
Roche axes 4 Chugai solid tumor assets in early-phase clear-out
Roche's CEO framed the actions as a continuation of the company's work to ensure candidates clear “the bar” before advancing.
Nick Paul Taylor
Oct 23, 2025 4:53am
Galapagos to wind down cell therapy unit, threatening 365 jobs
Oct 21, 2025 9:30am
BioNTech fades cancer vax in late-stage melanoma setting
Oct 20, 2025 3:01pm
Kardigan fashions $254M series B for late-stage pipeline
Oct 14, 2025 9:00am
AstraZeneca: Building a transparent pipeline from the ground up
Oct 10, 2025 9:52am
Takeda lays off 137 US staff as part of cell therapy retreat
Oct 1, 2025 3:13pm